Trademark: BRAFTOVI ENCORAFENIB CAPSULES
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
BRAFTOVI ENCORAFENIB CAPSULES
Click here to search for trademarks similar to BRAFTOVI ENCORAFENIB CAPSULES
Proof of use for BRAFTOVI ENCORAFENIB CAPSULES
We do not have any records of a proof of use for BRAFTOVI ENCORAFENIB CAPSULES at this moment.
Click here to add a proof of use for BRAFTOVI ENCORAFENIB CAPSULES
Possible trademark infringements of BRAFTOVI ENCORAFENIB CAPSULES
Basic Information about BRAFTOVI ENCORAFENIB CAPSULES
- Serial Number
- 87756187
- Filing Date
- 16 Jan 2018
- Registration Number
- 5625743
- Registration Date
- 11 Dec 2018
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of BRAFTOVI ENCORAFENIB CAPSULES on the blockchain with WikiTrademarks.io.
- First use of BRAFTOVI ENCORAFENIB CAPSULES anywhere
- BRAFTOVI ENCORAFENIB CAPSULES was first used on 02 Jul 2018 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns BRAFTOVI ENCORAFENIB CAPSULES?
1. Array Biopharma Inc. Boulder CO
2. Array Biopharma Inc. Boulder CO
3. Array Biopharma Inc. Boulder CO
Correspondent
- Heather A. McDonald Pfizer Inc.
- 66 Hudson Boulevard East
- New York, NY 10001-2192
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io